Cardiol Therapeutics Cash from Financing (TTM) Insights

Cardiol Therapeutics Inc (CRDL)

1.76 -0.08 (-4.35%) USD | NASDAQ | Apr 24, 16:00

1.76 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2018. Upgrade now.

Date	Value
December 31, 2023	-0.041M
September 30, 2023	-0.0417M
June 30, 2023	-0.0415M
March 31, 2023	-0.0414M
December 31, 2022	-0.0415M
September 30, 2022	47.36M
June 30, 2022	48.57M
March 31, 2022	65.79M
December 31, 2021	74.53M
September 30, 2021	27.14M
June 30, 2021	26.47M

Date	Value
March 31, 2021	20.90M
December 31, 2020	12.16M
September 30, 2020	12.15M
June 30, 2020	11.62M
March 31, 2020	0.2969M
December 31, 2019	1.529M
September 30, 2019	12.05M
June 30, 2019	13.48M
March 31, 2019	20.73M
December 31, 2018	19.51M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-0.0417M

Minimum

Sep 2023

74.53M

Maximum

Dec 2021

19.68M

Average

12.15M

Median

Sep 2020

Cash from Financing (TTM) Benchmarks